1,4-bis[(2,3-epoxypropoxy)methyl]cyclohexane

Skin irritation / corrosion

Administrative data

Endpoint:

skin irritation: in vitro / ex vivo

Type of information:

experimental study

Adequacy of study:

key study

Study period:

2013

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: The study was conducted according to OECD TG 439 and in accordance with the Principles of Good Laboratory Practices (GLP).

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2013

Report date:

2013

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)

Deviations:

no

Remarks:

Certain minor exceptions were noted but this had no overall impact to the study

Principles of method if other than guideline:

not applicable

GLP compliance:

yes

Test material

Test material information

Constituent 1

Reference substance name:

1,4-bis[(2,3-epoxypropoxy)methyl]cyclohexane

EC Number:

600-447-7

Cas Number:

14228-73-0

Molecular formula:

C14 H24 O4

IUPAC Name:

1,4-bis[(2,3-epoxypropoxy)methyl]cyclohexane

Test material form:

other: clear, colorless, semi-viscous liquid

Details on test material:

- Name of test material (as cited in study report): 1,4 Cyclohexanedimethanol Reaction Products with Epichlorohydrin
- Analytical purity: The purity of the test material was determined to be 9.5 area % 1,4-Cyclohexanedimethanol monoglycidiyl ether, 45.0 area %, 1,4-Cyclohexanedimethanol diglycidyl ether, and 25.0 area % of the reaction product of 1,4-cyclohexanedimethanol with 3 equivalents of epichlorohydrin by gas chromatography/flame ionization detector with tentative identification of the major components by nuclear magnetic resonance and gas chromatography mass spectrometry
- Impurities (identity and concentrations): no information available
- Lot number : Lot # 1H1050NZP1
- Expiration date of the lot/batch: March 05, 2015

Test animals

Species:

other: reconstituted huma epidermis model

Strain:

not specified

Details on test animals or test system and environmental conditions:

not applicable

Test system

Type of coverage:

other: not applicable

Preparation of test site:

other: not applicable

Vehicle:

unchanged (no vehicle)

Controls:

other: not applicable

Amount / concentration applied:

not applicable

Duration of treatment / exposure:

60 minutes

Observation period:

The skin irritation potential of the test substance was evaluated by measuring the relative cell viability in treated tissues at 42-hour post-exposure
incubation after a 60-minute exposure to the test substance.

Number of animals:

not applicable

Details on study design:

Upon receipt of the EpiDerm™ (MatTek Corporation), the solutions were stored as indicated by the manufacturer. The EpiDerm™ tissues were stored at 2-8ºC until used. On the day of receipt, an appropriate volume of fresh EpiDerm™ EPI-100-NMM Maintenance Medium was pre-warmed to room temperature. Nine-tenths (0.9) mL of Maintenance Medium were aliquotted into the appropriate wells of each 6-well plate, which were pre-labeled to indicate the test or control substance. Each EpiDerm™ tissue was inspected for air bubbles between the agarose gel and Millicell® insert prior to opening the sealed package. There was no tissue with air bubbles accounting for greater than 50% of the Millicell® area used in the assay. The 24-well shipping containers were removed from the plastic bag and their surfaces were disinfected with 70% ethanol. An appropriate number of tissues were removed from the 24-well shipping plate and transferred to the 6-well plate containing Maintenance Media. The plates were placed into the incubator at 37±1ºC in a humidified atmosphere of 5±1% CO2 in air (standard culture
conditions) for 60±5 minutes. At the end of the incubation period, the inserts were transferred into wells containing fresh Maintenance Medium and incubated overnight (18 ±3 hours) to acclimate the tissues.

The test substance was added to a 1.0 mg/mL MTT (Sigma) solution in warm MTT Addition Medium to assess its ability to directly reduce MTT. Approximately 25 mg of the test substance were added to 1 mL of the MTT solution, and the mixture was incubated in the dark at 37ºC for approximately one hour. The negative control, 30 μL of sterile, calcium and magnesium free Dulbecco’s Phosphate Buffered Saline (CMF-DPBS), was tested concurrently. If the MTT solution color turned blue/purple, the test substance was presumed to have reduced the MTT. The test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, was not observed to directly reduce MTT in the absence of viable cells.

Prior to performing the assay, the compatibility of the test substance with the nylon mesh was evaluated. Nylon meshes (Elko) were placed on a slide and 30 μL of the test substance was applied. A negative control, 30 μL of sterile, Calcium and Magnesium Free Dulbecco’s Phosphate Buffered Saline (CMF-DPBS) (Gibco, Lot # 1165768), was tested concurrently. The slides holding the treated meshes were placed into a Petri dish and incubated at standard culture conditions for 60±1 minutes. Using a microscope, each mesh was checked after 60 minutes of exposure to assess any interaction between the test substance and the mesh.
The test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, was not observed to interact with the nylon mesh, and therefore a nylon mesh was used to aid in the spreading of the test substance after dosing the EpiDerm™ tissues.

The pH of the test substance was measured using pH paper (EMD Chemicals Inc.). Initially, the test substance was added to pH paper with a 0-14 pH range in 1.0 pH unit increments to approximate a narrow pH range. Next, the test substance was added to pH paper with a narrower range of 5-10 pH units with 0.5 pH unit increments, to obtain a more accurate pH value.

The definitive assay included a negative control and a positive control. The negative control was 30 μL of 1 sterile, CMF-DPBS (Gibco, Lot # 1165768) and the positive control was 30 μL of 5% Sodium Dodecyl Sulfate (SDS) (Sigma). The 5% SDS was prepared by adding SDS powder (Sigma, Lot 069k0344v) in sterile deionized water (Quality Biological, Lot 719494). Both the positive and negative controls were tested in triplicate, and at the same exposure time as the test substance (60±1 minutes).

Definitive Test - The test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, was tested in one valid definitive trial. After the overnight incubation for 18±3 hours, the 6-well plates containing the EpiDerm™ tissues were removed from the incubator and placed at room temperature for at least 5 minutes prior to dosing. The EpiDerm™ tissues were treated in triplicate with the test substance for 60±1 minutes. Thirty microliters of the test substance were applied to each of three tissues at 1 minute intervals per tissue. A nylon mesh was placed gently over the dose to spread the test substance. If necessary, the mesh was gently pressed down to ensure even spreading. The EpiDerm™ tissues were tested in triplicate with the positive or negative control for 60±1 minutes. Thirty microliters of each control were applied to each of three tissues at 1 minute intervals per tissue. Immediately after control administration onto the tissue, a nylon mesh was placed gently over the dose to spread the negative and positive controls. The plates with dosed tissues were kept in the laminar flow hood until the last tissue was dosed. After the last tissue was dosed, all of plates were transferred to the incubator for 35±1 minutes at
standard culture conditions. After 35 minutes, all of the plates were removed from the incubator, placed into the laminar flow hood and kept at room temperature until the exposure period was completed for the first dosed tissue.

After 60 ± 1 minutes exposure, the EpiDerm™ tissues were rinsed with sterile, CMF-DPBS by filling and emptying the tissue insert 15 times. A stream of CMF-DPBS was directed onto the tissue surface. For the control substances where a mesh was used, the mesh was carefully removed with forceps (if necessary) after the 5th rinse. After the removal of the mesh, the rinsing procedure of the tissue continued for 10 times. After the 15th rinse, each of the 3 inserts per treatment group (test substance, positive, and negative control) was completely submerged, gently swirled, and the rinse media were added to a beaker containing approximately 150 mL of CMF-DPBS and specifically assigned/labelled for each treatment group; this procedure was repeated three times for each insert of each treatment group. Finally, the tissues were rinsed once more on the inside and outside of the tissue insert with sterile CMF-DPBS from the wash bottle, and the excess CMF-DPBS was decanted. The bottom of the tissue insert was blotted on sterile paper towels and the tissue surface was carefully blotted with sterile cottontipped applicators to remove any excess moisture. The tissue surface was visually observed for residual test substance or excess moisture using a dissecting scope. Once the rinsing was complete, the tissue inserts were transferred to new 6-well plates containing 0.9 mL of fresh Maintenance Medium. The tissues were then placed into the incubator at standard culture conditions for a post-treatment expression incubation of 24±1 hours.

After the 24±1 hour post-treatment expression incubation, the 6-well plates were removed from the incubator. The tissues were transferred into new 6-well plates pre-filled with 0.9 mL fresh Maintenance Medium warmed to approximately 37ºC. The tissues were placed back into the incubator for an additional 18±1 hours post-treatment incubation at standard culture conditions.

MTT Test - A 1.0 mg/mL solution of MTT prepared in warm MTT Addition Medium was prepared no more than 2 hours before use. Three hundred microliters of MTT solution were added to each designated well of a pre-labeled 24-well plate. At the end of the 42±2 hour incubation period, the EpiDerm™ tissues were blotted on sterile paper towels to remove any excessive moisture and then transferred to the appropriate well containing 0.3 mL of MTT solution. The plates were incubated at 37±1ºC for approximately 3±0.1 hours at standard culture conditions. After the MTT incubation, the EpiDerm™ tissues were submerged into 150 mL of CMF-DPBS, swirled, and the rinse media dumped out of the Millicell®. This process was performed three times. The tissues were then blotted on sterile paper towels, and transferred to a pre-labelled 24-well plate containing 2.0 mL of isopropanol in each designated well. The plates were covered with paraffin film, and shaken for at least 2 hours at room temperature to extract the MTT. At the end of the extraction period, the inserts were pierced with forceps and gently agitated up and down in their individual wells containing the isopropanol used for extraction. The tissue was then lifted to allow the extract to flow back into the well from which the insert was removed, and the insert was discarded. The extract solutions were mixed (homogenized by pipetting up and down three times) and two x 200 μL aliquots were transferred to the appropriate wells of a 96-well plate. Six x 200 μL aliquots of isopropanol were added to the wells designated as blanks. The absorbance at 570 nm (OD570) of each well was measured with a Molecular Devices Vmax plate reader, with AUTOMIX function selected.

Results and discussion

In vitro

Results

Irritation / corrosion parameter:

other: other: % viability

Value:

11.1

Remarks on result:

other:

Remarks:

Basis: mean. Time point: 60 minutes and a 42 hour post exposure incubation. Reversibility: no data. (migrated information)

Other effects / acceptance of results:

The skin irritation potential of the test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, was evaluated by measuring the relative cell viability in treated EpiDerm™ tissues after a 60-minute exposure and a 42-hour post-exposure incubation.
The mean OD570 of the negative control, CMF-DPBS, was 2.074. The mean viability of the positive control, 5% SDS, was 5.11%. The standard deviation calculated from individual percent tissue viabilities of the 3 identically treated replicates was < 18% for the positive control and negative control. Since the acceptance criteria were met, the assay was considered valid.
The test substance was not observed to directly reduce MTT in the absence of viable cells.
Based upon the results of this assay, the test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, was predicted to be irritating, and thus would require an R38 label.

Any other information on results incl. tables

SIT Results Using the EpiDerm™ Skin Model

Test substance	Concentration	% viable	R38 irritant	pH
1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin	Undiluted	11.1	yes	5.5
5% SDS (positive control)	NA	5.11	yes	NA

Applicant's summary and conclusion

Interpretation of results:

Category 2 (irritant) based on GHS criteria

Conclusions:

Based upon the results of this assay, the test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, was predicted to be a skin irritant according to the prediction model validated by ECVAM, and endorsed by the ECVAM Scientific Advisory Committee (ESAC) at its 29th meeting, held on 4-5th November 2008. The protocol met the requirements of the OECD guideline, “In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method” (TG 439). Accordingly, the test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, would be labeled a skin irritant, “R38” within the context of the European Risk Phrase system or a skin irritant, Category 2 as per the Guidance to Regulation (EC) No. 1272/2008 on classification, labelling and packaging (CLP) of substances and mixtures (2012)

Executive summary:

The MatTek Corporation’s EpiDerm ™ reconstituted human epidermis model was used to assess the potential skin irritation of the test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin (1,4-CHDM DGE). The skin irritation potential of the test substance was evaluated by measuring the relative cell viability in treated tissues at 42-hour post-exposure incubation after a 60-minute exposure to the test substance, according to the Protocol for: In vitro EpiDerm™ skin irritation test (EPI-200-SIT) evaluated and validated by the European Centre for the Validation of Alternative Methods (ECVAM). The protocol met the requirements of the OECD guideline, “In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method” (TG 439).

The test substance, 1,4-Cyclohexanedimethanol, reaction products with epichorohydrin, resulted in a 11.1% cell viability and was predicted to be a skin irritant. Results of the positive control and negative control met the criteria of a valid assay. Accordingly, the test substance, 1,4-Cyclohexanedimethanol, reaction products with epichlorohydrin, would be labeled a skin irritant, “R38” within the context of the European Risk Phrase system or a skin irritant, Category 2 as per the Guidance to Regulation (EC) No. 1272/2008 on classification, labelling and packaging (CLP) of substances and mixtures (2012).